Smoking stubbornly remains a leading cause of disease, disability and death in Canada, even as prevalence rates have fallen significantly over the last 50 years.
Pluri launches manufacturing division as cell therapy pipeline progresses – Pharmaceutical Technology
Share this article In an exclusive interview with Pharmaceutical Technology, Pluri’s CEO Yaki Yanay discussed the company’s recent contract manufacturing expansion. Credit: MagioreStock via Shutterstock.